Elkhorn Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Sell |
10,800
-200
| -2% | -$4.85K | 0.19% | 19 |
|
|
2025
Q1 | $279K | Buy |
11,000
+1,500
| +16% | +$38K | 0.18% | 18 |
|
|
2024
Q4 | $252K | Buy |
9,500
+3,400
| +56% | +$90.2K | 0.17% | 17 |
|
|
2024
Q3 | $177K | Sell |
6,100
-900
| -13% | -$26.1K | 0.11% | 20 |
|
|
2024
Q2 | $196K | Buy |
7,000
+1,600
| +30% | +$44.8K | 0.14% | 21 |
|
|
2024
Q1 | $150K | Buy |
5,400
+1,500
| +38% | +$41.7K | 0.11% | 23 |
|
|
2023
Q4 | $112K | Sell |
3,900
-1,400
| -26% | -$40.2K | 0.08% | 24 |
|
|
2023
Q3 | $176K | Buy |
5,300
+700
| +15% | +$23.2K | 0.12% | 23 |
|
|
2023
Q2 | $169K | Buy |
4,600
+400
| +10% | +$14.7K | 0.11% | 24 |
|
|
2023
Q1 | $171K | Buy |
+4,200
| New | +$171K | 0.11% | 22 |
|